Phentermine is one of the most widely prescribed weight-loss medications in the United States, and its side-effect profile is both well-studied and frequently misunderstood. The most common complaints are dry mouth, insomnia, and constipation, but the drug can also raise heart rate, affect mood, and in rare cases trigger serious events involving the eyes or the cardiovascular system. Because phentermine belongs to the amphetamine family, its safety reputation has been tangled up with the notorious “fen-phen” crisis of the 1990s, which colors how many people and clinicians think about the drug today.
The Everyday Side Effects Most People Notice
If you take phentermine, the side effects you’re most likely to experience are the ones tied to its stimulant nature. Dry mouth tops the list, followed by insomnia, constipation, and a jittery or “wired” feeling. A systematic review and meta-analysis of phentermine/topiramate trials found that dry mouth was roughly seven times more likely than with placebo, and constipation about two and a half times more likely.1PubMed. Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis A separate review of the combination therapy confirmed the same pattern: dry mouth, constipation, and insomnia were the most frequently reported complaints.2PubMed. A review of the metabolic effects of controlled-release Phentermine/Topiramate Studies comparing intermittent dosing (taking the drug on alternating months) with daily dosing have found the same side effects in both groups, with no clear advantage from the on-off schedule in terms of tolerability.3PubMed Central. Effects of Intermittent Versus Continuous Phentermine Therapy on Weight Reduction and Inflammatory Markers in Obese Non-diabetic Patients
Dizziness and difficulty concentrating also show up more often than with placebo. The same meta-analysis found that attention disturbance was about four and a half times more likely in treated participants, and dizziness roughly twice as likely.4PubMed. Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis For most people these effects are mild, tend to show up early in treatment, and often ease after a few weeks. Taking the dose in the morning rather than later in the day helps with insomnia specifically, since phentermine’s stimulant effect can last well into the evening.
What Phentermine Does to Blood Pressure and Heart Rate
Because phentermine releases norepinephrine, a natural concern is that it could push blood pressure or heart rate into dangerous territory. The clinical picture is more nuanced than that fear suggests. A long-term observational study tracking patients for up to a year found that blood pressure actually fell over time in people taking phentermine, likely because the weight they lost offset any direct pressor effect of the drug. Systolic blood pressure dropped by about 7 mmHg at six months and stayed there at one year, with no meaningful difference from an untreated comparison group.5PubMed. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity
Heart rate tells a slightly different story. A randomized, double-blind trial using continuous ambulatory blood pressure monitoring found that phentermine 30 mg raised average heart rate by about 6 beats per minute over eight weeks, while placebo actually lowered it by 1 beat per minute. That same trial also showed a small, non-significant bump in 24-hour systolic blood pressure of about 1.5 mmHg compared with placebo.6Obesity Pillars. Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity In practical terms, the blood pressure effects tend to be washed out by weight loss over the longer term, but the heart-rate increase is real and persistent. If you already have a resting heart rate on the high side, or if you have a history of arrhythmia, that 5-to-6 beat bump matters and is worth discussing with your prescriber.
The Fen-Phen Legacy and Heart Valve Concerns
Much of phentermine’s bad reputation traces back to the fenfluramine-phentermine (“fen-phen”) combination, which was wildly popular in the 1990s and then pulled from the market after reports of heart valve damage and pulmonary hypertension. A systematic review of that era’s data pooled six controlled studies and found that fen-phen users had roughly double the risk of aortic regurgitation compared with non-users.7BioMed Central / PubMed Central. Appetite suppressants and valvular heart disease – a systematic review Fenfluramine was the ingredient identified as the primary culprit. It flooded the body with serotonin, and serotonin acting on heart valve tissue is a well-established mechanism for producing the kind of fibrotic thickening that showed up on echocardiograms.
Phentermine alone has not been convincingly linked to the same valve damage, but the picture has a footnote. Laboratory work has shown that phentermine inhibits monoamine oxidase A (the enzyme that breaks down serotonin) at concentrations that overlap with what the drug achieves in the body. Researchers have argued that when phentermine was combined with fenfluramine, this MAO inhibition could have amplified fenfluramine’s serotonin release, making the combination far more dangerous than either drug alone.8PubMed. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors This is one reason phentermine’s prescribing label warns against combining it with serotonin-active drugs, including SSRIs and SNRIs. The concern is not that phentermine alone will damage your valves, but that mixing it with drugs that raise serotonin levels could recreate something like the fen-phen dynamic.
Pulmonary Hypertension
Pulmonary arterial hypertension (PAH), where the blood pressure in the arteries supplying the lungs rises dangerously, was the other headline-grabbing side effect from the fen-phen era. Fenfluramine and its close relatives are classified as definite risk factors for PAH. Phentermine’s role is less clear. A major analysis of appetite suppressants and PAH in 2000 did not retain phentermine as an independent risk factor, though the authors noted that decades of co-prescribing with fenfluramine made it difficult to rule phentermine out entirely.9European Respiratory Review. Drug-induced pulmonary arterial hypertension: a recent outbreak At least one isolated case report has described PAH developing in a patient taking phentermine alone, but isolated case reports are a long way from establishing causation.10PubMed Central. Pulmonary hypertension associated with use of phentermine
The bottom line here is that the pulmonary hypertension risk appears to have been driven primarily by fenfluramine-type drugs, not phentermine. Still, PAH is severe enough that it remains in the conversation whenever amphetamine-related appetite suppressants come up, and phentermine’s label reflects that caution.
Mood, Sleep, and Neuropsychiatric Effects
Phentermine works in part by increasing norepinephrine and, to a lesser extent, dopamine in the brain. That stimulant activity can produce effects that go well beyond appetite suppression. Insomnia is the most common neuropsychiatric side effect, but clinicians have also documented mood swings, anxiety, panic attacks, irritability, and agitation.11The Primary Care Companion for CNS Disorders. Weight Loss Medication Phentermine–Induced Hypomania in Bipolar Depression In people with bipolar disorder, phentermine has been reported to trigger hypomanic episodes, which is particularly dangerous because people in hypomania often feel better than usual and may not recognize the shift.
For someone with no psychiatric history, the most likely CNS-related side effects are restlessness and trouble sleeping. For someone already managing anxiety, depression, or a mood disorder, the stakes are higher. If you notice your mood becoming unusually elevated, your sleep deteriorating sharply, or your irritability spiking in a way that feels disproportionate, those are signals to contact your prescriber rather than wait it out.
Is Phentermine Addictive?
This is one of the most persistent questions about the drug, and the evidence is surprisingly reassuring. Phentermine is a Schedule IV controlled substance in the United States, which means regulators consider it to have a low but real potential for abuse compared with Schedule II stimulants like amphetamine itself. In practice, multiple studies of long-term use have failed to find signs of addiction in patients taking it for weight loss. One study that followed patients taking phentermine for up to 21 years found no evidence of drug craving, dose escalation, or amphetamine-like withdrawal upon stopping, even when patients stopped abruptly at doses higher than normally recommended.12PubMed. Addiction potential of phentermine prescribed during long-term treatment of obesity A more recent review concluded the same: there is no data supporting the idea that phentermine is addictive in a clinical weight-management setting.13PubMed. Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
That said, phentermine does share some pharmacological overlap with other stimulants. Animal studies from the 1980s showed that phentermine can produce effects in rats that partially mimic cocaine’s, and that chronic cocaine exposure creates cross-tolerance to phentermine. Those findings tell you something about shared receptor pathways, but they don’t translate neatly into real-world addiction risk in humans taking prescribed doses for weight management.14PubMed. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine The gap between “activates a similar pathway in rodent models” and “causes addiction in humans” is enormous, and the clinical data consistently falls on the side of phentermine being non-addictive at therapeutic doses.
What Happens When You Stop
Because of phentermine’s stimulant classification, many people worry about withdrawal. A dedicated study compared patients who abruptly stopped phentermine after long-term use with patients who had never taken it and with people recovering from actual amphetamine dependence. The phentermine group showed no significant difference from the never-treated group on withdrawal symptom scores. Meanwhile, the gap between the phentermine group and the amphetamine-dependent group was stark. Craving for the drug, the hallmark of stimulant withdrawal, was entirely absent in the phentermine-treated patients.15PubMed. A study of abrupt phentermine cessation in patients in a weight management program
What you can expect when you stop is a return of hunger and, often, some weight regain. These are not withdrawal symptoms in the medical sense; they represent the loss of the drug’s therapeutic effect. Your appetite goes back to its pre-treatment level because phentermine is no longer suppressing it. The distinction matters: genuine stimulant withdrawal involves fatigue, depression, agitation, and craving. The return of hunger after stopping phentermine is what happens when any appetite-suppressing intervention ends.16International Journal of Obesity. Addiction potential of phentermine prescribed during long-term treatment of obesity
Extra Risks When Phentermine Is Combined with Topiramate
Phentermine is sometimes prescribed on its own, but it is also available as a fixed-dose combination with topiramate (sold under the brand name Qsymia). The combination boosts weight loss, but it also introduces side effects that phentermine alone does not carry. Topiramate is an anticonvulsant with its own distinct side-effect profile, and the combination product adds concerns around birth defects, cognitive dulling, metabolic acidosis, and a class of tingling sensations called paresthesia.17PubMed Central. Clinical utility of phentermine/topiramate (Qsymiaâ„¢) combination for the treatment of obesity
The teratogenicity concern is especially important. Topiramate has been linked to an increased risk of oral clefts (cleft lip or palate) in babies exposed during pregnancy. One large study found that the prevalence of oral clefts among infants exposed to topiramate was roughly 2.5 to 5 times higher than in comparison groups.18PubMed. Topiramate use in pregnancy and the birth prevalence of oral clefts Because of this, anyone who could become pregnant is required to have a negative pregnancy test before starting the combination and to use effective contraception throughout treatment. This risk comes from the topiramate component, not phentermine, but it’s the single most serious safety concern with the combination product.
The meta-analysis of combination therapy trials also showed that paresthesia (tingling, especially in hands and feet) and dysgeusia (a metallic or altered taste) were dramatically more common with the combination than with placebo, each roughly eight to nine times more likely.19PubMed. Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis Both of these effects are topiramate-driven. If you’re taking phentermine alone and experiencing tingling or metallic taste, that’s unusual and worth investigating.
A Rare but Serious Eye Problem
One of the lesser-known side effects of phentermine is its potential to trigger acute angle-closure glaucoma, a sudden spike in eye pressure that can cause severe eye pain, blurred vision, and, if untreated, permanent vision loss. This has been documented with topiramate for years, but case reports have now described it occurring with phentermine alone. One report detailed bilateral acute angle closure in a patient taking phentermine monotherapy, with choroidal effusions strongly pointing to phentermine as the cause.20PubMed Central. Bilateral Acute Angle Closure Glaucoma Following Phentermine Monotherapy Another case described a 25-year-old woman who developed sudden myopia (nearsightedness) and angle closure after three weeks on phentermine, with symptoms resolving once the drug was stopped.21Journal of the Korean Ophthalmological Society. A Case of Phentermine Hydrochloride Induced Acute Myopia and Acute Angle Closure
The suspected mechanism involves swelling of the ciliary body and choroid in the eye, which pushes the lens-iris complex forward and physically blocks the drainage channel for fluid inside the eye. The result is a rapid pressure buildup. This is rare enough that many prescribers have never encountered it, but it is an emergency when it happens. If you develop sudden blurred vision, eye pain, or halos around lights while taking phentermine, you should treat it as urgent and seek immediate eye care rather than waiting to see if it passes.
Phentermine in Adolescents
With childhood obesity rates climbing, clinicians have started using phentermine in younger patients, though the evidence base is thinner than for adults. A case series of adolescents treated with phentermine monotherapy found that about 17% experienced side effects, but all of those resolved with a dose reduction or discontinuation, and no severe adverse events were recorded.22PubMed Central. Real-World Experience of the Efficacy and Safety of Phentermine Use in Adolescents: A Case Series A randomized trial of the phentermine/topiramate combination in adolescents found that about half of participants in the top-dose group reported at least one adverse event, a rate similar to placebo, though two serious adverse events did occur.23PubMed Central. Phentermine/Topiramate for the Treatment of Adolescent Obesity
The side-effect profile in teens appears broadly similar to what is seen in adults, with dry mouth and insomnia leading the list. Researchers have emphasized that phentermine in this age group should be combined with lifestyle interventions and closely monitored, partly because there is limited long-term data on the drug’s effects in developing bodies. This is an area where the evidence is still catching up to clinical practice.
Drug Interactions Worth Knowing About
Phentermine’s activity as a mild monoamine oxidase inhibitor, particularly of the MAO-A subtype that breaks down serotonin, creates a meaningful interaction risk. Taking phentermine alongside drugs that increase serotonin, including SSRIs, SNRIs, triptans, and other MAO inhibitors, could theoretically push serotonin levels high enough to cause serotonin syndrome, a potentially life-threatening condition marked by agitation, high body temperature, rapid heart rate, and muscle rigidity.24PubMed. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors Despite this pharmacological profile, phentermine has never been officially labeled as an MAO inhibitor, which means it has historically been co-prescribed with serotonergic drugs more casually than it probably should be.
Beyond serotonin-related interactions, phentermine can amplify the effects of other stimulants, including high doses of caffeine, and may interfere with blood pressure medications by counteracting their lowering effect. If you are on antihypertensives and start phentermine, your prescriber should be monitoring your blood pressure more closely in the first weeks, not because a crisis is likely, but because the two drugs are working against each other on one specific physiological target.
How Phentermine Compares with Newer Weight-Loss Drugs
The arrival of GLP-1 receptor agonists like semaglutide and liraglutide has shifted the obesity treatment landscape, and patients often want to know how phentermine’s side effects stack up. The side-effect profiles are quite different. GLP-1 drugs are dominated by gastrointestinal effects: nausea, vomiting, and diarrhea are the most common complaints and can be dose-limiting for some people. Phentermine’s side-effect profile leans more toward stimulant-type effects like insomnia and dry mouth, with relatively less gastrointestinal distress. A systematic review comparing multiple obesity drugs noted that gastrointestinal discomfort was more prominent with GLP-1 agonists and orlistat, while phentermine carried its own distinct concern around dependency, though as discussed, actual addiction data does not support that characterization in clinical use.25PubMed Central. Comparative Effectiveness of Semaglutide, Liraglutide, Orlistat, and Phentermine for Weight Loss in Obese Individuals: A Systematic Review
Phentermine also has a very different cost and accessibility profile. It is generic, inexpensive, and has been around for decades. The newer GLP-1 drugs are dramatically more expensive and can be difficult to access due to supply issues and insurance restrictions. For some patients, phentermine’s tolerability trade-offs are preferable, even if the newer drugs produce greater average weight loss. The choice is rarely about which drug is “better” in the abstract; it depends on which side effects a given person can tolerate, what their cardiovascular and psychiatric history looks like, and what is practical for their situation.